SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 10/25/16 Dupont E I De Nemours & Co 10-Q 9/30/16 84:10M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 704K 2: EX-12 Statement re: Computation of Ratios HTML 32K 3: EX-31.1 Certification -- §302 - SOA'02 HTML 32K 4: EX-31.2 Certification -- §302 - SOA'02 HTML 32K 5: EX-32.1 Certification -- §906 - SOA'02 HTML 26K 6: EX-32.2 Certification -- §906 - SOA'02 HTML 26K 13: R1 Document and Entity Information HTML 43K 14: R2 Consolidated Income Statements HTML 92K 15: R3 Consolidated Statements of Comprehensive Income HTML 90K 16: R4 Condensed Consolidated Balance Sheets HTML 122K 17: R5 Condensed Consolidated Balance Sheets HTML 36K (Parenthetical) 18: R6 Condensed Consolidated Statements of Cash Flows HTML 109K 19: R7 Summary of Significant Accounting Policies HTML 41K 20: R8 Proposed Merger with Dow Chemical HTML 32K 21: R9 Divestitures and Other Transactions HTML 77K 22: R10 Employee Separation / Asset Related Charges, Net HTML 83K 23: R11 Other (Loss) Income, Net HTML 83K 24: R12 Provision for Income Taxes HTML 29K 25: R13 Earnings Per Share of Common Stock HTML 68K 26: R14 Inventories HTML 36K 27: R15 Other Intangible Assets HTML 81K 28: R16 Short-Term and Long-Term Borrowings HTML 33K 29: R17 Commitments and Contingent Liabilities HTML 81K 30: R18 Stockholders' Equity HTML 269K 31: R19 Financial Instruments HTML 195K 32: R20 Long-Term Employee Benefits HTML 87K 33: R21 Segment Information HTML 158K 34: R22 Summary of Significant Accounting Policies Summary HTML 41K of Significant Accounting Policies (Policies) 35: R23 Divestitures and Other Transactions Divestitures HTML 67K and Other Transactions (Tables) 36: R24 Employee Separation / Asset Related Charges, Net HTML 74K (Tables) 37: R25 Other (Loss) Income, Net (Tables) HTML 84K 38: R26 Earnings Per Share of Common Stock (Tables) HTML 68K 39: R27 Inventories (Tables) HTML 36K 40: R28 Other Intangible Assets (Tables) HTML 78K 41: R29 Commitments and Contingent Liabilities (Tables) HTML 52K 42: R30 Stockholders' Equity (Tables) HTML 257K 43: R31 Financial Instruments (Tables) HTML 181K 44: R32 Long-Term Employee Benefits (Tables) HTML 82K 45: R33 Segment Information (Tables) HTML 157K 46: R34 Summary of Significant Accounting Policies Recent HTML 32K Accounting Pronouncements (Details) 47: R35 Proposed Merger with Dow Chemical (Narrative) HTML 26K (Details) 48: R36 Divestitures and Other Transactions (Narrative) HTML 103K (Details) 49: R37 Divestitures and Other Transactions (Schedule of HTML 59K results of operations from discontinued operations) (Details) 50: R38 Divestitures and Other Transactions (Schedule of HTML 32K cash flow information of discontinued operations) (Details) 51: R39 Employee Separation / Asset Related Charges, Net HTML 35K (La Porte) (Narrative) (Details) 52: R40 Employee Separation / Asset Related Charges, Net HTML 76K (2016 Restructuring Program schedule )(Details) 53: R41 Employee Separation / Asset Related Charges, Net HTML 57K (2014 Restructuring Program schedule) (Details) 54: R42 Employee Separation / Asset Related Charges, Net HTML 35K (Narrative) (Details) 55: R43 Employee Separation / Asset Related Charges, Net HTML 34K (Asset Impairment) (Narrative) (Details) 56: R44 Other (Loss) Income, Net (Schedule of Other HTML 55K Income) (Details) 57: R45 Other (Loss) Income, Net (Schedule of Foreign HTML 39K Exchange Gain (Loss)) (Details) 58: R46 Provision for Income Taxes (Details) HTML 29K 59: R47 Earnings Per Share of Common Stock (Earnings Per HTML 49K Share of Common Stock Reconciliation) (Details) 60: R48 Earnings Per Share of Common Stock (Schedule of HTML 30K Average Number of Antidilutive Stock Options) (Details) 61: R49 Inventories (Details) HTML 37K 62: R50 Other Intangible Assets (Schedule of Other HTML 71K Intangible Assets) (Details) 63: R51 Other Intangible Assets (Narrative) (Details) HTML 45K 64: R52 Short-Term and Long-Term Borrowings (Details) HTML 73K 65: R53 Commitments and Contingent Liabilities HTML 60K (Guarantees) (Details) 66: R54 Commitments and Contingent Liabilities HTML 97K (Litigation) (Narrative) (Details) 67: R55 Commitments and Contingent Liabilities HTML 38K (Environmental) (Narrative) (Details) 68: R56 Stockholders' Equity (Share Repurchase Program) HTML 54K (Narrative) (Details) 69: R57 Stockholders' Equity (Noncontrolling Interest) HTML 30K (Narrative) (Details) 70: R58 Stockholders' Equity (Schedule of Other HTML 197K Comprehensive Income) (Details) 71: R59 Stockholder's Equity (Schedule of Accumulated HTML 81K Other Comprehensive Loss) (Details) 72: R60 Financial Instruments (Schedule of Cash, Cash HTML 65K Equivalents and Marketable Securities) (Details) 73: R61 Financial Instruments (Debt) (Narrative) (Details) HTML 26K 74: R62 Financial Instruments (Notional Amounts of HTML 34K Derivatives) (Details) 75: R63 Financial Instruments (Effect of Cash Flows Hedges HTML 37K on Accumulated Other Comprehensive Income (Loss)) (Details) 76: R64 Financial Instruments (Schedule of the Fair Value HTML 52K of Derivative Instruments) (Details) 77: R65 Financial Instruments (Effect of Derivative HTML 67K Instruments) (Details) 78: R66 Long-Term Employee Benefits (Schedules of Net HTML 80K Periodic Benefit Cost) (Details) 79: R67 Segment Information (Schedule of Segment HTML 51K Information) (Details) 80: R68 Segment Information (Reconciliation to HTML 77K Consolidated Income Statements) (Details) 81: R69 Segment Information (Significant Pre-tax (charges) HTML 128K benefits not included in Segment Operating Earnings) (Details) 83: XML IDEA XML File -- Filing Summary XML 156K 82: EXCEL IDEA Workbook of Financial Reports XLSX 103K 7: EX-101.INS XBRL Instance -- dd-20160930 XML 3.95M 9: EX-101.CAL XBRL Calculations -- dd-20160930_cal XML 261K 10: EX-101.DEF XBRL Definitions -- dd-20160930_def XML 1.10M 11: EX-101.LAB XBRL Labels -- dd-20160930_lab XML 1.88M 12: EX-101.PRE XBRL Presentations -- dd-20160930_pre XML 1.20M 8: EX-101.SCH XBRL Schema -- dd-20160930 XSD 219K 84: ZIP XBRL Zipped Folder -- 0000030554-16-000156-xbrl Zip 322K
Exhibit |
1. | I have reviewed this report on Form 10-Q for the period ended September 30, 2016 of E. I. du Pont de Nemours and Company; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: | |
By: | /s/ Edward D. Breen |
Chair of the Board and | |
Chief
Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 10/25/16 | 8-K | ||
For Period end: | 9/30/16 | |||
List all Filings |